Figure S1. Analysis of Flavopiridol Effects on IFN-and Stress-Induced S727 Phosphorylation of STAT1 in Fibroblasts (A, B and C), of Flavopiridol Effects on STAT1 Promoter Recruitment (D), and of the Effects of Transcription Inhibition on S727 Phosphorylation of STAT1 (E)
(A) Flavopiridol inhibits IFN--and IFN--induced S727 phosphorylation of STAT1 in fibroblasts. Mouse fibroblasts were stimulated for 40 min with IFN-or IFN-after pretreatment or control treatment for 15 min with flavopiridol (FP) (500 nM). Cell extracts were analyzed by Western blotting using antibodies to phosphorylated S727 of STAT1 (pS727-STAT1), phosphorylated Y701 of STAT1 (pY701-STAT1) and STAT1 C-terminal antibody (not recognizing the STAT1 isoform).
(B) Flavopiridol inhibits IFN--but not stress-induced S727 phosphorylation of STAT1 in fibroblasts. Mouse fibroblasts were stimulated for 40 min with the stress inducer anisomycin (Aniso) or IFN-after pretreatment or control treatment for 15 min with flavopiridol (FP). Cell extracts were analyzed as in (A).
(C) Mouse fibroblasts were stimulated for 40 min with IFN-or left untreated followed 15 minpretreatment with flavopiridol (FP) at indicated concentrations. Cell extracts were analyzed as in (A).
(D) STAT1 promoter recruitment is not impaired by flavopiridol. MEFs were stimulated for 30 min with IFN-after pretreatment or control treatment for 30 min with flavopiridol (FP). Chromatin recruitment of STAT1 was analyzed by ChIP using STAT1 antibody or unspecific IgG. A representative gel with PCR-amplified Irf1 promoter using immunoprecipitated DNA as template is shown. Total chromatin DNA was amplified for input control.
(E) Ongoing transcription is not required for IFN--induced S727 phosphorylation of STAT1. MEFs were stimulated for 40 min with IFN-after pretreatment or control treatment for 15 min with actinomycin D (ActD). Cell extracts were analyzed by Western blotting using antibodies to phosphorylated S727 of STAT1 (pS727-STAT1), phosphorylated Y701 of STAT1 (pY701-STAT1) and total STAT1. (A) Quantitative analysis of effects of Cdk7, Cdk8 and Cdk9 silencing on IFN--induced STAT1 S727 phosphorylation. MEFs were treated for 48 h with siRNA to Cdk7, Cdk8, Cdk9 or control siRNA (Ctrl) and subsequently stimulated for 40 min with IFN-. Cell extracts of three experiments were analyzed by Western blotting using antibodies to phosphorylated S727 of STAT1 (pS727-STAT1), phosphorylated Y701 of STAT1 (pY701-STAT1) and total STAT1. The Western blot signal was quantified using the Odyssey Imager (LI-COR Biosciences), and the pS727 signals were normalized to total STAT1 signals. Values of the normalized pS727 signals for the individual Cdk siRNA relative to control siRNA (Ctrl) are depicted. Error bars represent standard deviations (SDs) (n = 3).
(B) Combined silencing of Cdk8 and Cdk9 does not result in more efficient inhibition of IFN--induced STAT1 S727 phosphorylation than silencing of Cdk8 alone. MEFs were treated for 48 h with siRNA to Cdk8, Cdk9, both Cdk8 + Cdk9 (Cdk8/9), or control siRNA (Ctrl) and subsequently stimulated for 40 min with IFN-or left unstimulated. Cell extracts were analyzed by Western blotting using antibodies to phosphorylated S727 of STAT1 (pS727-STAT1), phosphorylated Y701 of STAT1 (pY701-STAT1) and total STAT1. Silencing was confirmed by Western blotting of the same extracts using antibodies to CDK8 and CDK9. Equal loading was controlled by antibodies to ERK1/ERK2 (pan ERK).
(C) Silver stained gels of purified CDK8 module, TFIIH, and P-TEFb used for kinase assays.
(D) Stress-induced STAT1 S727 phosphorylation is not impaired in fibroblasts silenced for Cdk8. Fibroblasts silenced for the expression of Cdk8 or control-silenced cells were treated for 30 min with anisomycin (Aniso) or IFN-or left untreated. Cell extracts were analyzed using antibodies to phosphorylated S727 of STAT1 (pS727-STAT1), phosphorylated Y701 of STAT1 (pY701-STAT1) and total STAT1. Note that anisomycin does not cause Y701 phosphorylation. 
Promoters and to Chromatin (F), STAT1-Dependent Recruitment of CDK8 to TSS and Gene Body of Irf1 (E) and Effect of Missing TAD on Recruitment of MED1 and RNAPII (G)
(A-D) Recruitment of STAT1 precedes accumulation of S727-phosphorylated STAT1 at the Ggp2 and Tap1 promoters. Mouse fibroblasts were treated for indicated times with IFN-or left untreated. Association of STAT1 and S727-phosphorylated STAT1 with the Gbp2 (A) and Tap1 (C) promoters was examined by ChIP using respective antibodies or unspecific IgG. A representative gel with PCR-amplified Gbp2 or Tap1 promoters using immunoprecipitated DNA as template is shown. Total chromatin DNA was amplified for input control. Quantitative analysis (using ImageJ) of data shown in (A) and (C) is depicted in (B) and (D), respectively: the pS727 signal was normalized to input DNA after subtracting the signals of IgG. (A) Positions of the regulatory GAS and ISRE elements are marked. Note that GAS and ISRE in the Tap1 gene are downstream of the transcription start site. "Stop" marks the end of Irf1 (GenBank NM_001159393.1) and Tap1 (GenBank NM_013683.2) transcripts. Amplicons for ChIP analyses are depicted as TSS (transcription start site), GAS (GAS elements) and gene body with the approximate position relative to TSS.
(B) Ratios of S2-phosphorylated RNAPII to total RNAPII at TSS and the gene body of the Irf1 and Tap1 genes. WT MEFs treated for indicated times with IFN-were examined by ChIP using antibodies to RNAPII and pS2-RNAPII. Immunoprecipitated DNA was analyzed by qPCR for the both TSS and the gene body of Irf1 and Tap1, normalized to input DNA, and the ratios S2-phosphorylated RNAPII to total RNAPII were calculated. Error bars represent SDs (n = 3). (E) The procedure of siRNA transfection does not alter sensitivity of cells to VSV infection. STAT1 WT cells were treated with control siRNA (siCtrl) or were left untreated. After 24 h of incubation with IFN-at indicated concentrations cells were infected with VSV (MOI = 0.1), and the cell survival was monitored as in ( Figure 7F ). 
Figure S6. Control Experiments Showing Silencing Efficiency for
Genes are ordered according to their induction (log 2-transformed) by IFN-in WT cells (column: WT-g/WT-0). Fold difference (log 2) between S727A (SA) and WT cells is shown in the column "SA-g/WT-g". Genes that appear more than once have different probe set IDs for each listing. Data are extracted from the Table S4 . Genes are ordered according to their induction (log 2-transformed) by IFN-in WT cells (column: WT-g/WT-0). Fold difference (log 2) between S727A (SA) and WT cells is shown in the column "SA-g/WT-g". Genes that appear more than once have different probe set IDs for each listing. Data are extracted from the Table S4 Table S3 .
IFN--Induced Genes Not Significantly Affected by the STAT1 S727A Mutation
Genbank AC Gene symbol WT-g/WT-0
Genes are ordered according to their induction (log 2-transformed) by IFN-in WT cells (column: WT-g/WT-0). Genes that appear more than once have different probe set IDs for each listing. Data are extracted from the Table S4 . Genes significantly (p-value < 0.05) induced at least 2-fold by IFN-are shown (in alphabetical order). Fold differences (log 2-transformed) and p-values derived from three biological replicates for each condition are depicted. Key: WT = WT MEFs; SA = S727A MEFs; siCtrl = sample treated with control siRNA; siCdk8 = sample treated with Cdk8 siRNA; g = sample stimulated for 4 h with IFN-; 0 = sample not stimulated with IFN- IFN--induced genes (in alphabetical order) either down-regulated by both, the S727A mutation and Cdk8 silencing, or up-regulated under the same conditions. Genes that appear more than once have different probe set IDs for each listing. Data are extracted from the Table S4 .
Supplemental Experimental Procedures

RNAi-Mediated Silencing
Approx. 2x 10 5 (or 5x 10 5 ) MEFs were seeded in 3,5 cm (or 6 cm) format in DMEM supplemented with 10% FCS without antibiotics. Next day the medium was replaced with 2.5 ml (or 5 ml) fresh medium and cells were transfected with 50 pmol (or 100 pmol) ON-TARGET plus TM SMART pool siRNA (Dharmacon) using Lipofectamine TM RNAiMAX Reagent in Opti-MEM I (both Invitrogen). After 48 hours cells were used for whole cell extract preparation or RNA isolation.
Immunoblotting
Procedures for whole cell extracts, immunoprecipitation and immunoblotting were as described (Sadzak et al., 2008) . Primary antibodies used to detect proteins are described in antibody list (below).
Chromatin Immunoprecipitation
Chromatin Immunoprecipitation assay (ChIP) was performed as in (Hauser et al., 2002) with the following modifications. To pull down the antibodies Protein G Dynabeads (Invitrogen) were used. The amount of immunoprecipitated DNA was quantified in qPCR using Kapa Sybr Fast qPCR Universal Mix (Peqlab) and primers described in the primer list (below). All qPCRs were run on Mastercycler ep realplex 2 (Eppendorf). Values of immunoprecipitated DNA were shown as % input. Antibodies used in ChIP assay are specified in the antibody list (below).
Purification of Recombinant Proteins
Plasmids encoding STAT1 GST fusion proteins (GST-STAT1-WT aa711-750 and the corresponding S727A mutant) were described (Kovarik et al., 1999) . STAT3 and STAT5a GST fusion proteins (GST-STAT3-WT aa715-770 and the corresponding S727A mutant, GSTSTAT5a-WT aa704-793 and the corresponding S725A and S779A single mutants and S725A/S779A double mutant) were obtained by cloning the TADs into pGEX-4T1 (Promega). Standard techniques for expression and purification of GST fusion proteins were used. The four protein CDK8 module was expressed and purified according to (Knuesel et al., 2009b) . The TFIIH complex was purified from HeLa cells as described in (Knuesel et al., 2009a) . P-TEFb was isolated following recombinant expression in insect cells. Sf9 cells were co-infected with hightiter virus at a multiplicity of infection ratio of 1:2 (CDK9:Cyc T1) for 48 h at 27 o C. P-TEFb was purified from Sf9 cell pellets as described (Tahirov et al.) .
Kinase Assays
Reactions were performed with 1 μl CDK8 module, 1 μl TFIIH, and 0.75 μl P-TEFb with 500 ng GST-RNAPII CTD and 750 ng of GST-STAT-TAD (STAT1, STAT3, STAT5a and the corresponding mutants) or GST only in kinase buffer (25 mM Tris pH 8.0, 100 mM KCl, 100 μM ATP, 10 mM MgCl 2 , and 2 mM DTT) with 2.5 μCi [γ-32P]ATP at 30 o C for 60 min. SDS-PAGE was used to separate proteins and the gels were subsequently silver stained, dried at 55 o C for 60 min, exposed on a phosphor-imager screen for 18 h, and imaged using a Typhoon 9400 scanner. Quantitation of auto-rad bands was performed using ImageJ.
Microarray Analysis
STAT1 WT and STAT1 S727A MEFs were treated with siRNA as described above and stimulated with IFN-for 4 h or left untreated. Total RNA was isolated from cells using TRIzol reagent (Invitrogen) following the manufactures protocol and used for expression analysis using Agilent Whole Mouse Genome Microarrays, 8x60K. Standard protocols for labeling and hybridization were followed. In brief, fluorescent cRNA was generated using Low Input Quick
